Urothelial Cancers
Here below, you will find a list of all the latest content published on this website on the topic of Urothelial Cancers. The content is published in chronological order. Find out more about our content categorisation .
-
« Previous
- 1
- 2
- ...
- 15
-
Next »
- Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated...
- Long-term outcomes of bladder preservation in muscle-invasive bladder cancer patients
- An outcome analysis of robotassisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma
- Metastatic carcinoma gall bladder: A clinicoepidemiological profile of Indian patients
- Comparative analysis of first-line immune checkpoint inhibitor versus carboplatin-based chemotherapy for cisplatin-ineligible metastatic urothelial...
- EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial...
- Urachal Adenocarcinoma: Case Report
- Concurrent Atezolizumab-Radiotherapy in Locally Recurrent Urinary Bladder Carcinoma: A Case Report
- The evolving IO treatment landscape in UC
- Molecular dissection on bladder cancer
- Discussion led by moderator
- High incidence and mortality of transitional cell carcinoma in Thai kidney transplant patients
- Bladder
- 11th European Multidisciplinary Congress on Urological Cancers
- Participant Clinical Case Discussion: Meningism in a patient with Urothelial Cancer "When you have excluded the impossible.."
- Invited Discussant LBA14_PR
- IMvigor130: efficacy and safety from a Phase 3 study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs p...
- Pathologic outcomes after neoadjuvant chemotherapy for high-risk muscle invasive bladder cancer
- Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based...
- Hyperphosphatemia due to Erdafitinib (a Pan-FGFR Inhibitor) and Anti-tumor Activity Among Patients (Pts) with Advanced Urothelial Carcinoma (UC)
- Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second...
- Comparative analysis of tumor mutational burden (TMB) prediction methods and its association with determinants of the tumor immune microenvironment...
- The Immunoscore in patients with urothelial carcinoma treated with neoadjuvant chemotherapy: clinical significance for pathological response and su...
- Genomic analysis of urothelial cancer and associations with treatment choice and outcome
- A differential bladder microbiota composition is associated with tumor grade in bladder cancer.
-
« Previous
- 1
- 2
- ...
- 15
-
Next »